Thomas DesRosier, Senior VP General Counsel at GENZYME CORP (GENZ), sold 10,725 shares at $78.99 ($847K) on 2008-08-07, disclosed to the SEC on 2008-08-08.
Open-market sale of $847k GENZ by Senior VP General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MCRB | SELL | 2026-02-18 | $661 | — | Filing → |
| MCRB | SELL | 2025-11-18 | $1K | — | Filing → |
| MCRB | SELL | 2025-08-19 | $1K | — | Filing → |